CN104892597B - 络合萃取法分离纯化发酵液中的吡咯喹啉醌 - Google Patents
络合萃取法分离纯化发酵液中的吡咯喹啉醌 Download PDFInfo
- Publication number
- CN104892597B CN104892597B CN201510244788.5A CN201510244788A CN104892597B CN 104892597 B CN104892597 B CN 104892597B CN 201510244788 A CN201510244788 A CN 201510244788A CN 104892597 B CN104892597 B CN 104892597B
- Authority
- CN
- China
- Prior art keywords
- pqq
- zymotic fluid
- extraction
- ammoniacal liquor
- rich
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 38
- 238000000746 purification Methods 0.000 title claims abstract description 17
- 238000000926 separation method Methods 0.000 title claims abstract description 17
- 230000000536 complexating effect Effects 0.000 title claims abstract description 16
- 238000000605 extraction Methods 0.000 claims abstract description 62
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 32
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000007788 liquid Substances 0.000 claims abstract description 23
- 239000012043 crude product Substances 0.000 claims abstract description 20
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 18
- 239000012498 ultrapure water Substances 0.000 claims abstract description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 16
- 230000004151 fermentation Effects 0.000 claims abstract description 16
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000008139 complexing agent Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000006228 supernatant Substances 0.000 claims abstract description 11
- 239000003085 diluting agent Substances 0.000 claims abstract description 9
- 238000004108 freeze drying Methods 0.000 claims abstract description 9
- 238000000703 high-speed centrifugation Methods 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 230000001590 oxidative effect Effects 0.000 claims description 9
- 229910001868 water Inorganic materials 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 230000009514 concussion Effects 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 claims description 2
- 238000009776 industrial production Methods 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000590020 Achromobacter Species 0.000 description 2
- 241000862974 Hyphomicrobium Species 0.000 description 2
- 241000589344 Methylomonas Species 0.000 description 2
- 241000605118 Thiobacillus Species 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 241000590031 Alteromonas Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000862972 Ancylobacter Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000589236 Gluconobacter Species 0.000 description 1
- 241000589325 Methylobacillus Species 0.000 description 1
- 241000863391 Methylophilus Species 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 241000589506 Xanthobacter Species 0.000 description 1
- 241000235017 Zygosaccharomyces Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 102000003802 alpha-Synuclein Human genes 0.000 description 1
- 108090000185 alpha-Synuclein Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510244788.5A CN104892597B (zh) | 2015-05-14 | 2015-05-14 | 络合萃取法分离纯化发酵液中的吡咯喹啉醌 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510244788.5A CN104892597B (zh) | 2015-05-14 | 2015-05-14 | 络合萃取法分离纯化发酵液中的吡咯喹啉醌 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104892597A CN104892597A (zh) | 2015-09-09 |
CN104892597B true CN104892597B (zh) | 2016-05-04 |
Family
ID=54025610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510244788.5A Expired - Fee Related CN104892597B (zh) | 2015-05-14 | 2015-05-14 | 络合萃取法分离纯化发酵液中的吡咯喹啉醌 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104892597B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112194658A (zh) * | 2020-10-23 | 2021-01-08 | 内蒙古拜克生物有限公司 | 一种吡咯喹啉醌的分离纯化方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106188042B (zh) * | 2016-07-01 | 2018-01-05 | 郑州轻工业学院 | 采用分子印迹固相萃取法分离纯化发酵液中吡咯喹啉醌的方法 |
CN109943601B (zh) * | 2019-03-29 | 2022-09-09 | 新拓洋生物工程有限公司 | 利用2-酮基-l古龙酸结晶母液制备吡咯喹啉醌的方法 |
CN111440167A (zh) * | 2020-05-15 | 2020-07-24 | 山东惠仕莱生物科技有限公司 | 一种从发酵液中提取吡咯喹啉醌的方法 |
CN112358478B (zh) * | 2020-11-20 | 2021-07-23 | 郑州轻工业大学 | 一种利用超分子溶剂萃取法分离纯化吡咯喹啉醌的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0479890A (ja) * | 1990-07-24 | 1992-03-13 | Mitsubishi Gas Chem Co Inc | ピロロキノリンキノン類の回収・精製方法 |
CN1329004A (zh) * | 2000-06-20 | 2002-01-02 | 武汉大学 | 吡咯喹啉醌的提取方法 |
WO2006102642A1 (en) * | 2005-03-24 | 2006-09-28 | Clf Medical Technology Acceleration Program, Inc. | Synthesis of pyrroloquinoline quinone (pqq) |
CN102061278A (zh) * | 2010-11-17 | 2011-05-18 | 中国人民解放军军事医学科学院生物工程研究所 | 一种食甲基菌mp688及其应用 |
-
2015
- 2015-05-14 CN CN201510244788.5A patent/CN104892597B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0479890A (ja) * | 1990-07-24 | 1992-03-13 | Mitsubishi Gas Chem Co Inc | ピロロキノリンキノン類の回収・精製方法 |
CN1329004A (zh) * | 2000-06-20 | 2002-01-02 | 武汉大学 | 吡咯喹啉醌的提取方法 |
WO2006102642A1 (en) * | 2005-03-24 | 2006-09-28 | Clf Medical Technology Acceleration Program, Inc. | Synthesis of pyrroloquinoline quinone (pqq) |
CN102061278A (zh) * | 2010-11-17 | 2011-05-18 | 中国人民解放军军事医学科学院生物工程研究所 | 一种食甲基菌mp688及其应用 |
Non-Patent Citations (2)
Title |
---|
Total Synthesis of the Quinonoid Alcohol Dehydrogenase Coenzyme (1) of Methylotrophic Bacteria;E. J. Corey et al;《J. Am. Chem. Soc.》;19811231;第103卷;5599-5600 * |
吡咯喹啉醌生物合成研究进展;王歆等;《生物技术通讯》;20070531;第18卷(第3期);534-538 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112194658A (zh) * | 2020-10-23 | 2021-01-08 | 内蒙古拜克生物有限公司 | 一种吡咯喹啉醌的分离纯化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104892597A (zh) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104892597B (zh) | 络合萃取法分离纯化发酵液中的吡咯喹啉醌 | |
CN104328155B (zh) | 利用氧化葡萄糖杆菌生产吡咯喹啉醌的方法及应用 | |
CN108026132B (zh) | 一种烟酰胺单核苷酸的纯化方法 | |
CN103966274A (zh) | 一种以水产品及其加工下脚料为原料生物转化生产γ-氨基丁酸的方法 | |
CN109180674B (zh) | 基于发酵液复合盐析的吡咯喹啉醌二钠盐分离纯化方法 | |
JP2019506133A (ja) | 微細藻類からフコキサンチンおよび/またはポリサッカライドを生産するための改善されたプロセス | |
CN106544372A (zh) | 一种从发酵液中纯化γ‑氨基丁酸的方法 | |
CN1138776C (zh) | 吡咯喹啉醌的提取方法 | |
CN103739638B (zh) | 一种微生物发酵纯化茶皂素的方法 | |
CN101701069B (zh) | 一种提取ε-聚赖氨酸及其盐的方法 | |
CN108610258B (zh) | 一个新的酚酸类化合物及其制备方法和医药用途 | |
CN102942547A (zh) | 一种ga4和/或ga7的分离纯化方法 | |
CN103058877A (zh) | 一种利用色谱分离γ-氨基丁酸和谷氨酸的方法 | |
CN103224960B (zh) | 以圆酵母菌株连续发酵提取生产赤藓糖醇的方法 | |
CN103012107B (zh) | 一种从产丁二酸的发酵液中制备丁二酸胺的方法 | |
CN105732663B (zh) | 6‑氨基青霉烷酸的制备方法 | |
CN104031109A (zh) | 一种微生物发酵纯化茶皂素的方法 | |
CN116354917A (zh) | 一种金沙江石斛内生真菌色原酮类化合物dwt001及其制备和应用 | |
CN106188042B (zh) | 采用分子印迹固相萃取法分离纯化发酵液中吡咯喹啉醌的方法 | |
CN105294687B (zh) | 离子对双水相萃取分离吡咯喹啉醌的方法 | |
CN101709322A (zh) | 生物催化白桦脂醇合成白桦脂酸的方法 | |
CN102863433A (zh) | 莫匹罗星的一种纯化方法 | |
CN104017027B (zh) | 一种顺序式模拟移动色谱(ssmb)纯化海藻糖和葡萄糖的方法 | |
CN105837543A (zh) | 一种从发酵液中提取精制曲酸的方法 | |
CN102452916B (zh) | 一类芳香聚酮及其提取方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Xuepeng Inventor after: Ma Ke Inventor after: Zhong Guifang Inventor after: Hu Xianmei Inventor after: Ye Jianbin Inventor after: Shao Hua Inventor before: Yang Xuepeng Inventor before: Ma Ke Inventor before: Hu Xianmei Inventor before: Ye Jianbin Inventor before: Shao Hua |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160504 |